BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genzyme Corporation 

500 Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-252-7500 Fax: 617-252-7600


SEARCH JOBS



About Genzyme

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.

Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis.

Learn more at www.jobsatgenzyme.com.

Follow our jobs on Twitter www.twitter.com/genzymejobs.

Follow us on LinkedIn http://www.linkedin.com/company/genzyme.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


 Key Statistics


Email: AskGenzyme@genzyme.com
Ownership: Public

Web Site: Genzyme
Employees:
Symbol: GENZ
 



Industry
Biotechnology


Collaborations

Medtronic  Cardiac Cell Therapy

Cambridge Antibody Technology Group PLC   Antibodies against TGF-ß

Dyax Corp.  Hereditary Angioedema

Alnylam 





 Company News
Newton North High School Students Explore STEM Career Opportunities At Genzyme (GENZ) 4/16/2015 12:09:27 PM
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $14 Million Research Expansion With Genzyme (GENZ) 4/16/2015 10:17:10 AM
Genzyme (GENZ) To Present New Long-Term Data On Aubagio (teriflunomide) And Lemtrada (alemtuzumab) At American Academy of Neurology 4/13/2015 8:39:20 AM
Genzyme (GENZ) Not Moving Yet But Kendall Square Space Already Getting Massive Interest 4/2/2015 6:26:08 AM
Genzyme (GENZ)’s Cerdelga (eliglustat) Capsules Approved In Japan 3/30/2015 10:25:23 AM
Genzyme (GENZ) Convenes Sixth Annual Gaucher Leadership Forum 3/26/2015 12:47:27 PM
Genzyme (GENZ) Release: ENCORE Clinical Data Published In The Lancet Suggest Treatment With Oral Maintenance Therapy Effective In Previously Treated Gaucher Disease Patients 3/26/2015 9:23:00 AM
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million 3/5/2015 6:14:05 AM
Genzyme (GENZ) Recognizes International Rare Disease Day With Global Education And Fund-Raising Events; Announces Founding Partnership Of Give RARE 2/27/2015 8:25:48 AM
Genzyme (GENZ) Release: ENGAGE Randomized Clinical Trial Evaluating Cerdelga® (Eliglustat) For Treatment-Naïve Patients With Gaucher Disease Type 1 Published In JAMA 2/17/2015 11:09:59 AM
12345678910...